18F-AlF-NOTA-奥曲肽PET/CT在神经母细胞瘤中枢神经系统转移评估中的作用:初步研究
该回顾性分析纳入2021年1月至2024年7月间707次18F-AlF-NOTA-奥曲肽PET/CT检查,筛选出20例神经母细胞瘤中枢神经系统转移患儿(男18例、女2例,中位年龄59个月),共检出43个病灶,病灶检出总体灵敏度93.5%,小病灶(≤10 mm)灵敏度90.3%,结论认为该显像对中枢神经系统转移具有较高诊断灵敏度,可作为有价值的补充影像手段。
要点
- 20例神经母细胞瘤中枢神经系统转移患儿中,14例检出时无症状,5例为孤立性复发。
- 共检出43个中枢神经系统转移灶:软脑膜22个、硬脑膜13个、脑实质8个。
- 病灶中位最大径10 mm(四分位距7–13 mm,范围4–55 mm),65%(28/43)≤10 mm,总体病灶检出灵敏度93.5%,小病灶(≤10 mm)灵敏度90.3%。
核心结论
- 18F-AlF-NOTA-奥曲肽PET/CT对神经母细胞瘤中枢神经系统转移灶检出具有较高诊断灵敏度,可作为有价值的补充影像手段。
研究设计与样本
- 回顾性分析2021年1月至2024年7月间707次18F-AlF-NOTA-奥曲肽PET/CT检查,筛选报告以识别中枢神经系统转移患者,并逐一复核影像确认18F-AlF-NOTA-奥曲肽高摄取病灶。
- 共纳入20例神经母细胞瘤中枢神经系统转移患儿(男18例、女2例,中位年龄59个月),系统记录转移灶解剖部位、病灶数目及最大径。
主要发现
- 20例患儿中5例为孤立性复发,14例检出时无症状。
- 共检出43个中枢神经系统转移灶:软脑膜22个、硬脑膜13个、脑实质8个。
- 病灶中位最大径10 mm(四分位距7–13 mm,范围4–55 mm),65%(28/43)最大径≤10 mm。
- 病灶检出总体灵敏度93.5%,小病灶(≤10 mm)灵敏度90.3%。
临床怎么用
- 原文结论认为18F-AlF-NOTA-奥曲肽PET/CT对神经母细胞瘤中枢神经系统转移检出具有较高诊断灵敏度,可作为有价值的补充影像手段;原文未据此给出具体推荐条款。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the role of fluorine-18-Al-1,4,7-triazacyclononane-1,4,7-tri-acetate-octreotide ( 18 F-AlF-NOTA-octreotide) PET/CT in detecting central nervous system (CNS) metastases in neuroblastoma (NB). METHODS: A retrospective analysis was carried out on 707 18 F-AlF-NOTA-octreotide PET/CT examinations that were performed between January 2021 and July 2024. Reports were screened to identify patients with CNS metastases. Imaging data were then individually reviewed to confirm the presence of 18 F-AlF-NOTA-octreotide-avid lesions. CNS metastatic characteristics, including anatomic site (cerebral parenchyma, leptomeninges, and dura mater), lesion number, and maximum diameter, were systematically documented. RESULTS: A total of 20 children (18 boys and 2 girls; median age, 59 mo) diagnosed with CNS metastases from NB were included. Among them, 5 patients presented with isolated recurrence and 14 patients exhibited asymptomatic disease at the time of detection. A total of 43 CNS metastatic lesions were detected: 22 in the leptomeninges, 13 in the dura mater, and 8 in the cerebral parenchyma. Lesions had a median maximum diameter of 10 mm (interquartile range: 7-13 mm; range: 4-55 mm), with 65% (28/43) measuring ≤10 mm. The overall sensitivity for lesion detection was 93.5%, with 90.3% sensitivity for small lesions (≤10 mm). CONCLUSIONS: 18 F-AlF-NOTA-octreotide PET/CT demonstrates exceptional diagnostic sensitivity for detecting CNS metastases in NB, serving as a valuable complementary imaging modality.
引用
- Li S, Wang H, Liu J, et al. The Role of 18 F-AlF-NOTA-Octreotide PET/CT in the Evaluation of Central Nervous System Metastases in Neuroblastoma : A Preliminary Study. Clin Nucl Med. 2025. PMID: 40731330. doi:10.1097/RLU.0000000000006073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。